To ensure diversity and independence of Board members, directors shall be elected pursuant to the candidates nomination system in accordance with TSH Biopharm’s “Articles of Incorporation”, “Procedures for Election of Directors” and “Corporate Governance Best-Practice Principles”.

The Company's Board of Directors is currently set up with seven directors, three of which are independent directors.

The term of office of the current Board of Directors is from May 29, 2020 to May 28, 2023.



Board Members

Chairman Lin, Chuan

Current Position(s): Chairman, TTY Biopharm Company Limited

Ph.D., Economics, University of Illinois at Urbana-Champaign, USA

Director Hsiao, Carl

Current Position(s):
Director, TSH Biopharm Corporation Ltd.

PharmD, University of the Pacific Thomas J Long School of Pharmacy MBA, University of the Pacific Eberhardt School of Business

Director Chiang, Chao-I

Current Position(s):
Remuneration Committee Member, Pharma Engine

Bachelor’s Degree, Economics, Tung Hai University MA in Economics, University of Memphis

Director Chou, Kang-Chi

Current Position(s):
Chairman and CEO, IROC Co., Ltd.
Remuneration Committee Member, TSH Biopharm Corporation Ltd.
Independent Director, CCP Contact Probes Co., Ltd.
Independent Director, Radium Construction Co., Ltd.
Independent Director, Chant Sincere Co., Ltd.

International MBA, University of St. Thomas, Minnesota State, USA

Independent Director Wang, Chih-Li

Current Position(s):
Partner, Moores Rowland CPAs
Independent Director, Pharma Engine

Bachelor’s Degree in Accounting, Soochow University

Independent Director Wang, Yi-Min

Current Position(s):
Chairman, Yuanta Securities (Hong Kong) Co., Ltd.
Director, Yuanta Hong Kong Holdings (Cayman) Ltd.
Director, Yuanta Investment Management (Cayman)
Director, Yuanta Asia Investment (Hong Kong) Limited
Authorized Representative, Yuanta Securities Vietnam Limited Company

Master’s Degree in Accounting, National Changhua University of Education

Independent Director Chen, Rwei-Syun

Current Position(s):
Independent Director, Welgene Biotech Co., Ltd.

MBA, Columbia Business School, USA
Bachelor’s Degree in Biology, National Taiwan Normal University


According to Article 20 of the Company’s “Corporate Governance Best-Practice Principles” below:

  • Board Structure: Choose an appropriate number of board members, five to seven, in consideration of the Company’s business scale, the shareholdings of the Company’s major shareholders, and practical operational needs.
  • Directors concurrently serving as the Company’s managers shall not exceed one-third of the total number of the board members.
  • Basic requirements and values: Gender, age, nationality, and culture.
  • Professional knowledge and skills: A professional background (e.g., law, accounting, industry, finance, marketing, technology), professional skills, and industry experience.
  • Directors shall possess the following skills: operational judgement skills, accounting and financial analysis skills, operational management skills, crisis management skills, industrial knowledge, international market perspective, leadership skills, decision-making skills.


TSH Biopharm’s 5th session of Board of Directors is set up with seven directors, three of which are independent directors. According to the Company’s policy on diversity, the members are experts of industrial, academic and medical areas, covering finance, accounting and other professional fields. They are equipped with the knowledge, skills and competencies to perform their duties,

Please refer to the following table for the diversity of the Board members:

Core Items Nationality Gender Operation management Leadership decision Industry knowledge Finance Accounting Law
Position Name
Chairman Lin Chuan Taiwan Male V V V V V
Director CARL HSIAO U.S. Male V   V    
Director Chiang, Chao-I Taiwan Male       V V
Director Chou, Kang-Chi Taiwan Male V V V    
Independent director Wang, Chih-Li Taiwan Male       V V
Independent director Wang, Yi-Min Taiwan Male V     V V
Independent director Chen, Rwei-Syun Taiwan Female V   V    


The average age of the Board of Directors is 63.29. One director is 35 years old, one director is aged between 56-60, two directors are aged between 61-65, one director is aged between 70-75 and two between 76-80 years of age.
Concurrently an employee of the Company both accounts for 0% of directors and independent directors.
Female director accounts for 14.2% of Board members.
All three independent director tenure average below 3 years.


Succession Planning for Board Members and Important Management

Besides chairman and general manager, the Company also has directors for different functions. Due to sustainable development, the Company cultivates key talents for important management in various fields.

The Company has established the Talent Development Program since 2012 in order to cultivate a leader with three professional functions, including sales and marketing, research and development and management. Furthermore, the Company is constantly cultivating international market development staff and middle-level sales and marketing managers by Leadership Enhancement Action Plan. Leadership Enhancement Action Plan has been initiated since 2020.